OTC Healthcare in United Arab Emirates

Table of Contents

• 1. EXECUTIVE SUMMARY
• 2. OPERATING ENVIRONMENT
• 2.1 OTC Registration and Classification
• 2.2 Vitamins & Dietary Supplements Registration and Classification
• 2.3 Advertising
• 2.4 Packaging and Labelling
• 2.5 Distribution
• 2.6 De-listing or De-reimbursement
• 2.7 Traditional Remedies
• 2.8 Homeopathy
• 2.9 Generics
• 2.10 Consumer Expenditure on Health Goods and Medical Services
  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2000-2005
• 2.11 Life Expectancy
  • Table 2 Life Expectancy at Birth 2000-2005
• 3. OTC HEALTHCARE SALES
• 3.1 Market Performance
  • Table 3 Retail Sales of OTC Healthcare by Sector: Value 2000-2005
  • Table 4 Retail Sales of OTC Healthcare by Sector: % Value Growth 2000-2005
• 3.2 Switches
• 3.3 Competitive Environment
  • Table 5 OTC Healthcare Company Shares by Retail Value 2001-2005
  • Table 6 OTC Healthcare Brand Shares by Retail Value 2002-2005
• 3.4 Leading Company Profile: Bayer AG
• 3.5 Leading Company Profile: Julphar Gulf Pharmaceuticals
• 3.6 New Product Developments
• 3.7 Retail Distribution
  • Table 7 Retail Sales of OTC Healthcare by Distribution Format: % Analysis 2000/2005
  • Table 8 Retail Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2005
• 3.8 Retailer Activity and Private Label Trends
• 3.9 Forecast Market Performance
  • Table 9 Forecast Retail Sales of OTC Healthcare by Sector: Value 2005-2010
  • Table 10 Forecast Retail Sales of OTC Healthcare by Sector: % Value Growth 2005-2010
• 4. DEFINITIONS